Bismuth Subsalicylate
Best-in-class: Bismuth Subsalicylate
The pink stuff. An old drug with genuinely good evidence for two specific jobs — and a couple of properties nobody warns you about.
Bismuth Subsalicylate quick facts
| Suggested dose | 524 mg every 30–60 min as needed, max 8 doses/day, short-term only. H. pylori regimens are prescriber-directed. |
| How often | as needed |
| Who it's for | Travellers' diarrhea, and as part of a prescribed H. pylori regimen. |
Genuinely multi-mechanism and clinically established, particularly in traveller's diarrhea and H. pylori regimens. Two things to know: it contains salicylate, so it interacts with anticoagulants and is contraindicated in children with viral illness because of Reye's syndrome risk. The black tongue and black stools are harmless bismuth sulfide and alarm people unnecessarily.
How Bismuth Subsalicylate actually works
Acts by several routes at once: it binds to and coats the gastric mucosa, has direct antibacterial and antiviral activity, reduces intestinal secretion through the salicylate moiety, and disrupts bacterial biofilm. That last property is why it appears in H. pylori quadruple therapy — biofilm is a major reason resistant infections survive antibiotics.
Where to get Bismuth Subsalicylate
Find Bismuth Subsalicylate on iHerb →What it is, why it recurs, and where this fits — free to read.
The evidence for Bismuth Subsalicylate
Graded by what exists behind each claim.
✅ Clinically validated
- Effective for prevention and treatment of travellers' diarrhea in randomized trials.
- A standard component of bismuth quadruple therapy for Helicobacter pylori eradication, which is now first-line in many regions because of clarithromycin resistance.
- Antimicrobial and antisecretory activity plus a coating effect on the gastric mucosa.
📊 Correlative data
- Over a century of population-scale over-the-counter use, which is where the safety profile and the harmless black tongue and stool come from. Also long documented in traveller's diarrhea prophylaxis before the trials existed.
🧪 Theoretical / extrapolated benefits
- Sometimes used for bile acid diarrhea and for sulfur-producing gut overgrowth on the basis of bismuth binding hydrogen sulfide — plausible, thinly evidenced.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Bismuth Subsalicylate actually does
This is one molecule that becomes two drugs in the stomach, and almost nobody is told about the second one. Bismuth subsalicylate is a poorly soluble bismuth salt of salicylic acid. In gastric acid it dissociates: the bismuth precipitates as insoluble oxychloride and other bismuth species that stay in the lumen, and the salicylate is released, absorbed, and behaves exactly like the salicylate from aspirin. Two compartments, two pharmacologies, one tablet.
Run the formula weights, because this is the number the label does not print. Bismuth subsalicylate is C7H5BiO4, formula weight about 362. The salicylate anion is 137. So salicylate is 137/362 = about 38% of the tablet by mass. A 262 mg tablet carries roughly 99 mg of salicylate; a 524 mg dose carries about 199 mg; and the label maximum of eight 524 mg doses in a day is about 4.2 g of bismuth subsalicylate delivering roughly 1.6 g of salicylate. For scale, a 325 mg aspirin tablet carries about 247 mg of salicylate, so a full day at the label maximum is a salicylate load in the region of six or seven regular aspirin.
The bismuth half acts locally and does several things at once. Bismuth compounds bind to the gastric mucus layer and to ulcer bases, form a protective complex, and act directly on Helicobacter pylori — disrupting the cell envelope, inhibiting urease and interfering with adhesion and ATP generation. Bismuth-based drugs have been reviewed as a therapeutic class for precisely this combination of properties Keogan 2014. The important consequence is that this action is not receptor-mediated, which is why H. pylori resistance to bismuth has not emerged.
The salicylate half explains the antisecretory and antidiarrheal effect. Salicylate inhibits prostaglandin synthesis, and in the intestine that reduces the prostaglandin-driven secretion that produces watery stool. So the two halves are not redundant: the bismuth is antimicrobial and mucosa-protective in the lumen, and the salicylate is antisecretory both locally and systemically.
The black tongue and black stool are a sulfide reaction and they double as a mechanistic clue. Bismuth reacts with hydrogen sulfide generated by oral and colonic bacteria to form bismuth sulfide, which is black and insoluble. That is harmless, and it is also the chemistry behind the proposal that bismuth reduces intestinal hydrogen sulfide — a plausible mechanism with thin clinical evidence behind it.
Bismuth absorption is small and it is not zero. Only a tiny fraction of an oral dose is absorbed, but bismuth is eliminated slowly and accumulates in tissue with prolonged high-dose use, which is the basis of the toxicity question that has been reviewed directly as a barrier to wider therapeutic use of bismuth compounds Gonçalves  2024.
Cell, rodent, human — and where it stops
Two indications carry real guideline-level evidence, and they are narrow and specific.
Travelers' diarrhea. A graded expert panel report sets out prevention and treatment of travelers' diarrhea, and bismuth subsalicylate appears there as a prophylactic and symptomatic option with a defined place relative to antibiotics and loperamide Riddle 2017. Note what that placement implies: it is an option for a defined risk period, not a standing medication.
Helicobacter pylori eradication. Bismuth-containing quadruple therapy is a first-line regimen in national guidance, and the reason it has risen to first-line is clarithromycin resistance rather than any new bismuth data Zhou 2022. Bismuth adds efficacy against resistant strains without itself selecting resistance Keogan 2014, which is an unusual property worth naming.
The obstacle in this category is the opposite of the usual one. Most supplement pages have to explain that a laboratory result has never been tested in people. Here the human evidence is solid and the gap is that the evidence belongs to short, defined courses Riddle 2017 Zhou 2022 while the product is available in a large bottle with no natural stopping point.
And the second obstacle is that the salicylate is invisible in the clinical framing. The trials and the guidelines describe a bismuth intervention. The pharmacology at the label maximum is also a salicylate intervention in the gram-per-day range, computed above from the formula weight. Anyone already taking aspirin, or with a salicylate sensitivity, is being dosed twice and only one of those doses is written down.
Where the evidence thins fastest is the fashionable use. Bismuth for bile acid diarrhea and for sulfide-producing overgrowth rests on the sulfide chemistry and on the recognized mucosal effects Keogan 2014, without randomized trials at those indications. That is a plausible extension, and calling it plausible rather than evidenced is the difference between the two halves of this page.
Bismuth Subsalicylate — which form, and does it matter
Bismuth salts are not interchangeable, and the one difference that matters most is whether salicylate comes with it. Bismuth subcitrate potassium, the agent used in many quadruple-therapy regimens Zhou 2022, delivers bismuth with no salicylate at all. Bismuth subsalicylate delivers roughly 38% of its mass as salicylate. Bismuth subnitrate and subgallate are older preparations. Choosing between them is choosing a salicylate exposure, and the choice is usually made by which one the pharmacy sells.
Elemental bismuth content is the number a clinician thinks in and a consumer never sees. Guideline regimens specify bismuth doses Zhou 2022, and a consumer label specifies milligrams of the salt. Because the salts differ in bismuth fraction, the two cannot be compared without doing the arithmetic, and nothing on the packet invites anyone to do it.
Chewable, caplet and liquid differ in where the drug arrives and when. A chewed tablet or a liquid coats the esophagus and stomach directly and starts working on contact, which suits an upper gastrointestinal or antisecretory purpose. A swallowed caplet delivers the dose lower. For the coating effect the format is part of the mechanism, not a preference.
Bismuth is a heavy metal, so co-timing with other things is a form question. Polyvalent metal ions bind tetracyclines and fluoroquinolones in the gut and cut their absorption — which is awkward, because tetracycline is a component of classical bismuth quadruple therapy Zhou 2022 and the spacing of the components is part of why those regimens are prescriber-directed rather than assembled at home.
And the form nobody should improvise is the long one. The toxicity review of bismuth compounds frames accumulation as the barrier to broader therapeutic use of this class Gonçalves  2024. Short defined courses at label doses are a different exposure from months of daily use, and only one of those has been studied Riddle 2017.
What would have to be true, and how you would know it was not
1. Predict black stool and a black tongue, and predict they are not blood. Bismuth reacts with bacterial hydrogen sulfide to form black bismuth sulfide. Predict this within a day or two of starting, predict it resolves within a few days of stopping, and predict it is matte black rather than the tarry, offensive-smelling stool of upper gastrointestinal bleeding. Getting this wrong in either direction — panic, or dismissal of a real bleed — is the commonest clinical consequence of this product.
2. Predict a salicylate effect proportional to the arithmetic. At the label maximum the daily salicylate load is roughly 1.6 g by formula weight. Predict measurable platelet inhibition and, in anyone anticoagulated, predict a rising INR on warfarin. Markers: INR, and any bruising or bleeding. Retest window: within one week of starting a full-dose course. Predict tinnitus as the classic early sign of salicylate excess, particularly in renal impairment or in someone also taking aspirin.
3. Predict the eradication regimen works and the supplement version does not. In H. pylori, predict that bismuth as part of a guideline quadruple regimen contributes meaningfully to eradication Zhou 2022 and predict that bismuth alone eradicates nobody. Marker: urea breath test or stool antigen, at least four weeks after finishing therapy and off acid suppression. That timing is part of the prediction: testing too early produces false negatives.
4. The prediction that argues against long-term use. Predict that with months of daily dosing, tissue bismuth accumulates and the risk profile changes from the short-course one the guidelines describe Gonçalves  2024 Riddle 2017. Predict that neurological symptoms — confusion, tremor, myoclonus, ataxia — are the presentation to watch for, and that they are a reason to stop and seek assessment rather than to reduce the dose.
5. Predict antibiotic absorption falls if the timing is careless. Predict measurably reduced tetracycline or fluoroquinolone absorption when taken with bismuth, and predict separating them restores it. This one is invisible without a drug level and its consequence is treatment failure.
What nobody has tested yet
Nobody has established the safe cumulative bismuth dose. The toxicity of bismuth compounds is reviewed as the barrier to their wider use Gonçalves  2024, and the practical question — how many grams over how many weeks before tissue levels matter — has no published threshold. Every recommendation is therefore of the form “short courses” without a number behind it.
Nobody has measured the salicylate exposure in real users. The arithmetic above comes from a formula weight. Plasma salicylate in people taking this at label doses, with and without concurrent aspirin, has not been published, and it is a single-afternoon study with a direct safety implication.
Nobody has tested the hydrogen sulfide claim. Bismuth binds sulfide Keogan 2014; whether that translates into symptom improvement in people with sulfide-predominant overgrowth is untested by any randomized trial, and breath sulfide is now measurable. That is a trial somebody could design this year.
And nobody has compared subsalicylate with subcitrate head to head outside eradication. The two salts deliver the same metal with and without a gram-scale salicylate load. For a person who needs bismuth's local action but should not have salicylate, that comparison would be decisive, and it has not been made Zhou 2022.
Bismuth Subsalicylate — its own safety story, not its category's
Read the salicylate line first, because it is the one that puts people in hospital. Roughly 38% of this tablet by mass is salicylate, and a full day at the label maximum delivers about 1.6 g of it. That means every aspirin caution applies: do not use it with a salicylate or NSAID allergy, do not stack it with aspirin, and treat the anticoagulant interaction as pharmacodynamic — additive bleeding risk that does not show up as a changed drug level, only as bruising, nosebleeds or a raised INR.
Do not give it to a child or teenager with a viral illness. Salicylates in that setting carry the Reye's syndrome association, which is the reason aspirin left pediatric practice. A product most people file mentally under “stomach medicine” carries the same warning, and that mismatch is why it needs stating plainly.
Prolonged high-dose use is the bismuth risk, and it is neurological. The toxicity of bismuth compounds is reviewed as the principal obstacle to their therapeutic use Gonçalves  2024, and encephalopathy — confusion, tremor, myoclonus, unsteadiness — is the presentation. This is a short-course medicine Riddle 2017 Zhou 2022, not a daily supplement, and the label's own limits exist for this reason.
Kidney function changes both halves of the calculation. Salicylate elimination is renal and bismuth clearance is slow to begin with, so impaired kidney function raises exposure to both components simultaneously Gonçalves  2024. Anyone with chronic kidney disease should not be self-dosing this.
Two absorption interactions with practical consequences. Bismuth binds tetracyclines and fluoroquinolones and reduces their absorption, which matters most when bismuth is part of the same regimen Zhou 2022. And the black stool can mask genuine gastrointestinal bleeding in exactly the population — people on salicylate and anticoagulants — most likely to be bleeding.
Who should not take it. Children and teenagers with a viral illness; anyone with aspirin or NSAID allergy; anyone anticoagulated without a conversation first; anyone with chronic kidney disease; anyone pregnant, where salicylate exposure is a considered clinical decision rather than a self-care one; and anyone whose diarrhea is bloody, febrile or lasting beyond 48 hours, which is a reason to be assessed rather than medicated. Nothing here is a diagnosis or a prescription, and the eradication regimens described above are prescriber-directed by design Zhou 2022.
Sources read for this page
- Riddle MS. Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report. J Travel Med 2017 · PMID 28521004
- Zhou L. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment. Chin Med J (Engl) 2022 · PMID 36579940
- Gonçalves Â. Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?. Int J Mol Sci 2024 · PMID 38338879
- Keogan DM. Current and Potential Applications of Bismuth-Based Drugs. Molecules 2014 · PMID 25251194
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Stool frequency across a defined episode. Travelers' diarrhea over days rather than weeks is what the trials measured. Inside a prescribed Helicobacter pylori regimen the read-out is not symptoms at all — eradication is confirmed by breath or stool testing after the course, and feeling fine is not that test.
- How long before it means anything: Hours to a couple of days, then stop. This is a short-term tool with a hard ceiling rather than a supplement, and prolonged high-dose use carries a real risk of bismuth neurotoxicity.
- What will fool you: Black tongue and black stool arrive within a day and are harmless, and people read them either as bleeding or as proof of potency — neither is true. Travelers' diarrhea also settles by itself in a few days, so the dose taken on day three collects the credit for day four.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Bismuth Subsalicylate — safety & side effects
- Harmless black tongue and black stool — alarming and universal. Do not confuse it with the black stool of GI bleeding, which is tarry and foul.
- It is a salicylate. Additive bleeding risk with anticoagulants and antiplatelets — warfarin, apixaban, rivaroxaban, clopidogrel, and aspirin at any dose. The interaction is pharmacodynamic rather than metabolic, so it does not show up as a changed drug level; it shows up as bruising, nosebleeds or a raised INR. Do not use with aspirin allergy, and do not give it to children or teenagers with a viral illness — Reye's syndrome risk.
- Avoid in pregnancy. Reduces absorption of tetracyclines and quinolones. Neurotoxicity with prolonged high-dose use is documented.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Bismuth Subsalicylate in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Bismuth Subsalicylate
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 103 markers A–Z
Bismuth Subsalicylate — frequently asked questions
What is Bismuth Subsalicylate?
The pink stuff. An old drug with genuinely good evidence for two specific jobs — and a couple of properties nobody warns you about.
What is the suggested dose of Bismuth Subsalicylate?
524 mg every 30–60 min as needed, max 8 doses/day, short-term only. H. pylori regimens are prescriber-directed. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Bismuth Subsalicylate dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Bismuth Subsalicylate?
Coach Cam sources Bismuth Subsalicylate from vetted, top-rated brands on iHerb — use the buy link on this page.
What Bismuth Subsalicylate is used for
Bismuth Subsalicylate appears under 1 goal in the goal router.
Related Gut & Digestion supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.